In terms of revenue, the global live cell encapsulation market was valued at US$ 285 Mn in 2020 growing at a CAGR of 3.2% over the forecast period (2021 – 2029).
According to the Absolute Markets Insights report, alginate accounted for the largest market share in 2020 in the live cell encapsulation market. Alginate hydrogels are attractive in wound healing, drug delivery, and tissue engineering applications to date, as these gels retain structural similarity to the extracellular matrices in tissues. Also, the drug molecules, from small chemical drugs to macromolecular proteins, can be released from alginate gels in a controlled manner. Moreover, the alginate gels can be orally administrated or injected into the body in a minimally invasive manner, which allows extensive applications in the pharmaceutical arena. Development of products with alginate is further driving the market. For instance, Living Cell Technologies Limited, an Austral-Asian biotechnology company developed a product, NTCELL which is an alginate-coated capsule containing clusters of neonatal porcine choroid plexus cells.
Get PDF sample report with all related graphs & charts (pre and post covid-19 impact analysis): https://www.absolutemarketsinsights.com/request_sample.php?id=1074
The drug delivery segment dominated the market as microencapsulation offers various significant advantages as a drug or treatment delivery system. It offers an effective protection of the encapsulated active agent or encapsulated live cells against degradation or destruction by the immune system. There is increased possibility to accurately control the release rate of an incorporated drug over period of hours to months. Moreover, it offers an easy administration and offers provision of desired, pre-programmed drug-release profiles which match the therapeutic needs of the patient. The nanoparticle based drug delivery systems have shown many advantages in cancer treatment, such as good pharmacokinetics, precise targeting of tumor cells, reduction of side effects, and drug resistance, thereby inducing the segment growth in the global live cell encapsulation market.
The cancer segment dominates the live cell encapsulation market due to increasing R&D for product development of cancer therapy as cell encapsulation technology is a novel strategy for human anti-tumor immunotherapy. Also, it provides accurate and targeted drug delivery to cancerous cell without interactions with healthy cells. Moreover, several nanocarriers have been approved in clinical cancer chemotherapy and have showed significant improvement in therapeutic efficiency.
North America holds the prominent share, owing to the surge in research activities related to cell encapsulation and rise in public & private investments in healthcare, which is driving the live cell encapsulation market demand in this region. Moreover, the increasing cancer patient pool in the region, the presence of key players and numerous government initiatives are other factors propelling the market growth. However, Asia Pacific region in the live cell encapsulation market is expected to grow at the fastest rate over the forecast period, owing to increasing M&A activities, new product launch and rising disease burden. For instance, Living Cell Technologies has formed a joint venture with Japan’s Otsuka Pharmaceutical Factory to develop LCT’s DIABECELL, which comprises of encapsulated insulin-producing pig cells that are used with an aim to treat people with type 1 diabetes.
Speak to our analyst in case of queries before buying this report: https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=1074
How Absolute Market Insights is unique in nature?
The research report on Global Live Cell Encapsulation Market will include extensive information based on the following pointers:
- Global Market size and forecast values (2015 – 2029), in terms of revenue (US$ Million) by segments/sub-segments; wherein 2015 to 2019 has been considered as historic years, 2020 as the base year, while 2021 to 2029 has been considered as the forecast period.
- Split of the market revenue (US$ Million) into all the relevant segments & sub-segments across all major regions/countries.
- Market Determinants and Influencing Factors
- Macro-Economic and Micro-Economic Indicators
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Challenges
- Trends on Global Live Cell Encapsulation Market
- Exclusive Details on the Effect of the Pandemic
- Porter’s Five Forces Analysis
- Competitor Landscape
- Product Benchmarking
- Market Share Analysis, 2020
- Global Presence and Growth Strategies
- The final report will include competitive product benchmarking which will include comparison of different products offered by different market participants on the basis of their features and capabilities that will help you to understand their market offerings. Furthermore, for each company, we will provide information regarding company details, company overview, product offerings, key developments, financial analysis, and SWOT analysis and business strategies.
- We offer our report in different languages which include German, French, Spanish, Japanese and Korean amongst others.
View our exclusive press releases on Industry Global News24
Competitor Insights:
The key companies profiled in the global live cell encapsulation market are mentioned below:
- Austrianova
- Blacktrace Holdings Ltd.
- Büchi Labortechnik AG
- Defymed
- Evonik Industries
- Gloriana Therapeutics
- Merck KGaA
- PharmaCyte Biotech Inc.
- Sigilon Therapeutics, Inc.
- Other Market Participants
Global Live Cell Encapsulation Market Polymeric Material Outlook (Revenue, USD Million, 2015 - 2029)
- Cellulose
- Alginate
- Chitosan
- Others
Global Live Cell Encapsulation Market Application Outlook (Revenue, USD Million, 2015 - 2029)
- Drug Delivery
- Research
- Regenerative Medicine
- Cell Transplantation
- Others
Global Live Cell Encapsulation Market Disease Indication Outlook (Revenue, USD Million, 2015 - 2029)
- Cancer
- Diabetes
- Others
Global Live Cell Encapsulation Market Regional Outlook (Revenue, USD Million, 2015 - 2029)
- North America (U.S., Canada, Mexico, Rest of North America)
- Europe (France, The UK, Spain, Germany, Italy, Nordic Countries, Benelux Union, Rest of Europe)
- Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
- Latin America (Brazil, Argentina, Rest of Latin America)
Purchase the latest in-depth Live Cell Encapsulation Market report: https://www.absolutemarketsinsights.com/checkout?id=1074
Browse more trending reports by Absolute Markets Insights:
The single –use sterile devices market was estimated to be US$ 1159.67 million in 2020 and is expected to grow at CAGR of 15.9% over the forecast period. In terms of revenue, the single –use sterile devices market is anticipated to reach US$ 5381.71 million by 2029.
The global Biobanking market was valued at US$ 2202.01 Mn in 2020 growing at a CAGR of 7.1% over the forecast period (2021 – 2029).
The global vitamins supplements market is anticipated to grow from US$ 100.51 billion in 2021 to $161.56 billion in 2028 at a CAGR of 6.1% in the forecast period.
The global Digital biomarkers market was valued at US$ 4521.62 Mn in 2020 and is growing at a CAGR of 25.67% over the forecast period (2021 – 2029).
Global Massage Guns Market is Expected to Grow at a CAGR of 9.8% by 2027, Owing to its Application in Improving Athletes' Performance, Says Absolute Markets Insights
Global Telehealth for Women's Reproductive and Sexual Health Market is Expected to Reach US$ 215.70 Million by 2027, Growing at an Estimated CAGR of 16.6% Over the Forecast Period
Glance through Absolute Markets Insights plethora of reports on Healthcare Category
Contact Us:
Company: Absolute Markets Insights
Email Id: [email protected]
Phone: IN +91-7400-242424 , US +1-510-420-1213
Contact Name: Shreyas Tanna
Website: www.absolutemarketsinsights.com/